Ziopharm Offering Could Raise $63.5M for Trials Expansion
By Tom Wall
Friday, February 4, 2011
Ziopharm Oncology Inc. could raise as much as $63.5 million through an underwritten public offering of 9.6 million shares of common stock priced at $5.75 per share about 7 percent below Wednesday's closing price and an underwriter's 30-day option to purchase as many as 1.4 million additional shares.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.